High and Sustained Ex Vivo Frequency but Altered Phenotype of SARS-CoV-2-Specific CD4
CD39
CD4+ T-cells
CD73
COVID-19
MHC class II Tetramer
PD-1
SARS-CoV-2
T-cell memory
TIGIT
anti-CD20 therapy
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
10 06 2022
10 06 2022
Historique:
received:
01
05
2022
revised:
31
05
2022
accepted:
08
06
2022
entrez:
24
6
2022
pubmed:
25
6
2022
medline:
28
6
2022
Statut:
epublish
Résumé
Here, we longitudinally assessed the ex vivo frequency and phenotype of SARS-CoV-2 membrane protein (aa145-164) epitope-specific CD4
Identifiants
pubmed: 35746736
pii: v14061265
doi: 10.3390/v14061265
pmc: PMC9228841
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : U19 AI135817
Pays : United States
Organisme : NIH HHS
ID : NIDDK 3U19AI135817-04S1
Pays : United States
Références
Cytometry A. 2011 Feb;79(2):167-74
pubmed: 21265010
J Infect. 2020 Aug;81(2):e16-e25
pubmed: 32335169
Hum Immunol. 2017 Feb;78(2):88-94
pubmed: 27780790
N Engl J Med. 2020 Dec 3;383(23):2291-2293
pubmed: 33176080
Front Oncol. 2020 Sep 02;10:1578
pubmed: 32984017
Front Immunol. 2020 Aug 26;11:1870
pubmed: 32983106
Nat Med. 2020 Sep;26(9):1428-1434
pubmed: 32661393
Immunity. 2011 Jan 28;34(1):108-21
pubmed: 21215658
Cell. 2021 Feb 18;184(4):861-880
pubmed: 33497610
Nat Immunol. 2011 Jun;12(6):492-9
pubmed: 21739672
J Exp Med. 2007 Jun 11;204(6):1257-65
pubmed: 17502665
Lancet Rheumatol. 2022 Jan;4(1):e33-e41
pubmed: 34806036
Clin Exp Immunol. 2022 Apr 4;207(2):227-236
pubmed: 35020841
J Infect Dis. 2020 Sep 1;222(7):1103-1107
pubmed: 32702095
Eur J Immunol. 2022 Feb;52(2):312-327
pubmed: 34752634
Cell Rep. 2021 Jul 20;36(3):109414
pubmed: 34260965
PLoS Pathog. 2021 Sep 16;17(9):e1009842
pubmed: 34529740
Blood. 2022 Jan 6;139(1):142-147
pubmed: 34669919
Eur J Immunol. 2007 Jan;37(1):100-9
pubmed: 17171760
Cancers (Basel). 2022 Apr 11;14(8):
pubmed: 35454831
BMC Immunol. 2012 Apr 11;13:17
pubmed: 22489829
Cell. 2020 Nov 12;183(4):996-1012.e19
pubmed: 33010815
Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5610-5
pubmed: 15044705
Nat Commun. 2021 Nov 4;12(1):6405
pubmed: 34737266
JCI Insight. 2020 Oct 15;5(20):
pubmed: 32937615
J Acquir Immune Defic Syndr. 2017 Apr 1;74(4):467-472
pubmed: 27930600
Purinergic Signal. 2020 Sep;16(3):389-401
pubmed: 32754836
PLoS Pathog. 2021 Dec 29;17(12):e1010203
pubmed: 34965282
Cell Rep. 2021 Feb 9;34(6):108728
pubmed: 33516277
J Infect Dis. 2014 May 1;209(9):1321-30
pubmed: 24357632
J Exp Med. 2003 Dec 15;198(12):1807-15
pubmed: 14676295
Front Immunol. 2022 Jun 06;13:886646
pubmed: 35734162
AIDS. 2015 Nov;29(17):2245-54
pubmed: 26544698
Cancer Discov. 2022 Jan;12(1):62-73
pubmed: 34753749
Front Immunol. 2022 Apr 22;13:867167
pubmed: 35529864
J Clin Virol. 2020 Jul;128:104390
pubmed: 32388471
J Immunol. 2009 Feb 15;182(4):1868-76
pubmed: 19201839
Annu Rev Immunol. 2012;30:429-57
pubmed: 22224772
Nat Med. 2021 Nov;27(11):1990-2001
pubmed: 34522051
J Virol. 2011 Feb;85(3):1287-97
pubmed: 21047964
J Leukoc Biol. 2017 May;101(5):1263-1271
pubmed: 28193736
Int J Hyg Environ Health. 2021 Mar;232:113671
pubmed: 33338782
Immunity. 2020 Aug 18;53(2):442-455.e4
pubmed: 32668194
J Leukoc Biol. 2013 Oct;94(4):551-61
pubmed: 23709688
Infect Immun. 2015 May;83(5):2043-52
pubmed: 25733518
PLoS Pathog. 2021 Jul 16;17(7):e1009761
pubmed: 34270631
J Exp Med. 2012 Jan 16;209(1):61-75
pubmed: 22213804
Ann Oncol. 2010 Sep;21(9):1870-1876
pubmed: 20157180
J Clin Invest. 2021 Mar 1;131(5):
pubmed: 33427749
Clin Infect Dis. 2021 Dec 6;73(11):e4020-e4024
pubmed: 33103195
N Engl J Med. 2021 Aug 5;385(6):562-566
pubmed: 34347959
N Engl J Med. 2017 Oct 5;377(14):1331-1344
pubmed: 28976863
Int J Hyg Environ Health. 2021 Sep;238:113851
pubmed: 34601375
Am J Transplant. 2010 Nov;10(11):2410-20
pubmed: 20977632
J Leukoc Biol. 2022 Apr 5;:
pubmed: 35384035
J Immunol. 2000 Nov 15;165(10):5558-65
pubmed: 11067910
N Engl J Med. 2004 Jun 17;350(25):2572-81
pubmed: 15201414
Nature. 2009 Sep 10;461(7261):282-6
pubmed: 19741708
Microbiol Resour Announc. 2020 Jun 4;9(23):
pubmed: 32499358
Mult Scler Relat Disord. 2022 Jan;57:103382
pubmed: 35158475
Int J Mol Sci. 2018 Apr 18;19(4):
pubmed: 29669994
J Clin Invest. 2020 Dec 1;130(12):6588-6599
pubmed: 32841212
Cell Rep Med. 2020 Sep 22;1(6):100081
pubmed: 32839763
Oncoimmunology. 2020 Apr 9;9(1):1744946
pubmed: 33457090
J Neurol. 2021 Jan;268(1):5-7
pubmed: 32654064
Nat Commun. 2021 May 10;12(1):2593
pubmed: 33972535
Nature. 2021 Apr;592(7853):277-282
pubmed: 33545711
Front Immunol. 2021 May 03;12:645989
pubmed: 34012436
J Immunol. 2014 Feb 15;192(4):1597-608
pubmed: 24453250
Immunity. 2019 May 21;50(5):1132-1148
pubmed: 31117010
Nat Rev Immunol. 2003 Apr;3(4):269-79
pubmed: 12669018
N Engl J Med. 2017 Jan 19;376(3):209-220
pubmed: 28002688
Immunity. 2018 Feb 20;48(2):202-213
pubmed: 29466753
Vaccine. 2021 Apr 8;39(15):2110-2116
pubmed: 33744048
Philos Trans R Soc Lond B Biol Sci. 2000 Mar 29;355(1395):351-5
pubmed: 10794053
Nat Commun. 2021 Aug 17;12(1):4984
pubmed: 34404803
Immunity. 2020 Dec 15;53(6):1245-1257.e5
pubmed: 33326767
Cells. 2020 Jul 22;9(8):
pubmed: 32707842
Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20388-93
pubmed: 19918053
Immunity. 2021 Jan 12;54(1):44-52.e3
pubmed: 33338412
J Clin Invest. 2012 Sep;122(9):3271-80
pubmed: 22922259
Immunol Rev. 2017 Mar;276(1):121-144
pubmed: 28258700
Purinergic Signal. 2022 Mar;18(1):93-113
pubmed: 34997903
J Rheumatol. 2008 May;35(5):826-33
pubmed: 18398943